Open AccessThe Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Author(s) -
Ameet Sarpatwari,
Aaron S. Kesselheim
Publication year - 2016
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.1001955
Subject(s) - trademark , brand names , business , drug approval , drug , drug industry , generic drug , medicine , advertising , political science , pharmacology , microbiology and biotechnology , law , biology
Ameet Sarpatwari and Aaron Kesselheim explore whether stripping branded drugs of trademark protection would improve the efficiency and fairness of health care.